Exabis Library
Welcome to the e-CCO Library!
P649: Anti-TNF agent drug survival in patients with IBD: real-world comparisons of individual anti-TNF agents based on the Swedish National Quality Registry for IBD (SWIBREG)
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P649: Comparison of the KU Leuven ustekinumab concentration assay and the antibodies-to-ustekinumab assay with assays developed at Janssen R&D and used in clinical studies of IBD patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P649: Does serum triiodothyronine-to-thyroxine (T3/T4) ratio predict therapeutic outcome to anti-TNF therapies in biologic-naïve patients with active luminal Crohn's disease?
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P649: Does switching to low dose thiopurine and allopurinol prevent IBD patients with evidence of hypermethylation on standard dose thiopurines from developing hepatotoxicity and drug side effects?
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P649: The impact of COVID-19 on quality of life among patients with inflammatory bowel diseases – A Danish prospective population-based cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P649: Ulcerative Colitis Narrative Japanese survey: Identifying gaps between patient and healthcare professional perspectives on communication and disease management to optimise patient care
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P650 Outcomes of endoscopic balloon dilation for luminal strictures in Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P650: A trend to higher adoption of mesalazine suppository use for UC patients in 15 European countries
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P650: Combination therapy for perianal fistulising Crohn’s disease in biological era: What is the optimal time for surgical intervention?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P650: IBD care from the patient perspective: The patient's turn
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P650: Integrin expression patterns of patients with IBD treated with vedolizumab.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P650: Mechanisms of Infliximab failure: the predictive role of MMP3
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P650: The prognostic impact of radical resection margins on the Recurrence of Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P651 Does ambient temperature alter faecal calprotectin levels?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P651: Barriers to clinical research in children with inflammatory bowel disease: the patients' perspective
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P651: Comparison of Adverse Events of SARS-CoV-2 Vaccination between Patients with Inflammatory Bowel Disease and Healthcare Workers
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P651: Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn’s disease: data from administrative databases in Tuscany, Italy
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P651: Disease severity and intensity of therapy predicts serious adverse events in paediatric ulcerative colitis: the DEVELOP experience
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P651: Reliability of blood tests, neutrophil lymphocyte ratio (NLR) and Glasgow prognostic index (GPI) to evaluate the severity of the Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM